GlassScriptPhysician profile
Carly Bramel
NPI 1174061980
$4,004.13
in general payments reported to CMS, 2019-2025
14 companies · $3,536 in 2025
The $3,536 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $272 · 2022: $18.20 · 2023: $139 · 2024: $38.67 · 2025: $3,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,460 · Travel and Lodging: $712 · Food and Beverage: $508 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,460.00 |
| Travel and Lodging | $711.51 |
| Food and Beverage | $507.94 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $3,429.09 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $170.65 | 2022-2025 | Dupixent |
| Abbvie INC. | $78.21 | 2021 | |
| Csl Behring | $57.70 | 2021 | |
| Amgen INC. | $48.24 | 2025 | |
| Optinose US, INC. | $45.00 | 2025 | |
| Mauna Kea Technologies, INC. | $38.67 | 2024 | |
| Novo Nordisk INC | $28.67 | 2021 | |
| Melinta Therapeutics, LLC | $25.92 | 2021 | |
| Amarin Pharma, INC. | $21.07 | 2021 | |
| Allergan, INC. | $17.69 | 2021 | |
| Esperion Therapeutics, INC. | $15.72 | 2021 | |
| Lilly USA, LLC | $15.51 | 2021 | |
| Avanir Pharmaceuticals, INC. | $11.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carly Bramel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.